| 영문 | hives, urticaria | 한글 | 두드러기 |
|---|---|---|---|
| 설명 | 두드러기는 임상적으로 매우 흔히 관찰되는 피부질환으로서 사람의 일생 중에 적어도 한번 두드러기를 경험하는 비율은 15내지 20%에 이른다. 두드러기는 피부 또는 점막의 깊은 부위가 일시적으로 붓는 현상(부종)을 말한다. 대개 혈관의 투과성의 증가로 혈액중의 액체성분이 피부, 점막 등으로 빠져나와 그곳에 고여서 생긴다. 부종이 피하조직 또는 점막조직까지 확대되어 임상적으로 커다란 덩이를 형성한 것을 맥관부종이라고 부른다. 편의상 두드러기는 급성과 만성으로 구분하는데 일반적으로 수일 또는 수주간 지속한 후에 완전히 소실되는 경우를 급성 두드러기, 지속적 또는 간헐적으로 적어도 6주이상 경과하는 경우를 만성 두드러기라 한다. 원인은 어떤 종류의 식물(예: 굴, 조개 등), 약물(예: 페니실린), 감염, 감정적 스트레스 등이다. 치료는 항히스타민제의 투여이다. |
||
| HIV | Human Immunodeficiency Virus |
|---|---|
| HIV | human immunodeficiency virus |
| HIV | Ag human immunodeficiency virus antigen |
| HIV-G | human immunodeficiency virus-associated gingivitis |
| HIV1 | human immunodeficiency virus type 1 |
| HIVAN | human immunodeficiency virus-associated nephropathy |
| HIVD | Herniation(Herniated) of Inter-Vertebral Disc - Cervical HIVD ▣ Complications 1. Cervical Rib 2. Compression of Brachial Plexus - Lumbar HIVD ▣ Complications 1. 1o & metastatic Tumor 2. Spinal Injury & Anomaly 3. Hypertrophy of Spine 4. other Disease of Spine & Pelvic Bone 5. Tumors of Pelvis |
| CD4 | HIV helper cell count |
|---|---|
| CD8 | HIV suppressor cell count |
| IWB | indeterminate [HIV-1] Western blot; index of well being |
| p24 | HIV antigen |
| HIV | Anti-human immunodeficiency virus |
|---|---|
| HIV | Human immunodefiency virus |
| HIV | Human Immunodeficiency Virus I |
| HIV | Human Immunodeficiency Virus Type-1 |
| HIV | Human immunodeficiency virus infection |
| HIV AN | HIV associated nephropathy |
| HIV Pr | HIV protease |
| HIV+ | HIV positive |
| HIV+ | HIV seropositive |
| HIV+ | Human immunodeficiency virus-positive |
| MOS-HIV | Medical Outcome Study HIV Health Survey |
|---|---|
| anti-HIV | Anti-human immunodeficiency virus |
| Anti-HIV-1 | Anti-human immunodeficiency virus type 1 |
| HAD | HIV associated dementia |
| AIDS | HIV)-acquired immunodeficiency syndrome |
| HIV | <virology> A type of retrovirus (human immunodeficiency virus) that is responsible for the fatal illness acquired immunodeficiency syndrome. Two strains have been identified. Type 1: the retrovirus recognised as the agent that induces AIDS. Type 2: a virus closely related to HIV-1 that also leads to immune suppression. HIV-2 is not as virulent as HIV-1 and is epidemic only in West Africa. Acronym: HIV (11 Nov 1997) |
|---|---|
| HIV antibodies | Antibodies reactive with human immunodeficiency virus (HIV, previously called HTLV-III/lav) antigens of aids. This includes HIV-1 antibodies and HIV-2 antibodies. (12 Dec 1998) |
| HIV antigens | Antigens associated with specific proteins of the human adult T-cell immunodeficiency virus (HIV); also called HTLV-III-associated and lymphadenopathy-associated virus (lav) antigens. (12 Dec 1998) |
| HIV core protein p24 | A major core protein of the human immunodeficiency virus encoded by the HIV gag gene. HIV-seropositive individuals mount a significant immune response to p24 and thus detection of antibodies to p24 is one basis for determining HIV infection by elisa and western blot assays. The protein is also being investigated as a potential HIV immunogen in vaccines. (12 Dec 1998) |
| HIV encephalopathy | <immunology> A frequent cerebral condition in people with AIDS that results in the loss of cognitive capacity, affecting the ability to function in a social or occupational setting. Its cause has not been determined exactly, but may result from HIV infection of cells in the brain or an inflammatory reaction to such infection. (09 Oct 1997) |
| HIV enhancer | Cis-acting regulatory sequences in the HIV long terminal repeat (ltr) which play a major role in induction or augmentation of HIV gene expression in response to environmental stimuli such as mitogens, phorbol esters, or other viruses. The HIV enhancer is the binding site for many cellular transcription factors including the nuclear factor nf-kappa b. (12 Dec 1998) |
| HIV enteropathy | Chronic, well-established diarrhoea (greater than one month in duration) without an identified infectious cause after thorough evaluation, in an HIV-positive individual. It is thought to be due to direct or indirect effects of HIV on the enteric mucosa. HIV enteropathy is a diagnosis of exclusion and can be made only after other forms of diarrhoeal illness have been ruled out. (12 Dec 1998) |
| HIV envelope protein gp120 | External envelope protein of the human immunodeficiency virus which is encoded by the HIV env gene. It has a molecular weight of 120,000 kD and contains numerous glycosylation sites. Gp120 binds to cells expressing CD4 cell-surface antigens, most notably t4-lymphocytes and monocytes/macrophages. Gp120 has been shown to interfere with the normal function of CD4 and is at least partly responsible for the cytopathic effect of HIV. (12 Dec 1998) |
| HIV envelope protein gp160 | An envelope protein of the human immunodeficiency virus that is encoded by the HIV env gene. It has a molecular weight of 160,000 kD and contains numerous glycosylation sites. It serves as a precursor for both the HIV envelope protein gp120 and the HIV envelope protein gp41. (12 Dec 1998) |
| HIV envelope protein gp41 | Transmembrane envelope protein of the human immunodeficiency virus which is encoded by the HIV env gene. It has a molecular weight of 41,000 and is glycosylated. The n-terminal part of gp41 is thought to be involved in cell fusion with the CD4 antigens of t4 lymphocytes, leading to syncytial formation. Gp41 is one of the most common HIV antigens detected by immunoblotting. (12 Dec 1998) |
| HIV infections | Includes the spectrum of human immunodeficiency virus infections that range from asymptomatic seropositivity, thru aids-related complex (arc), to acquired immunodeficiency syndrome (aids). (12 Dec 1998) |
| HIV integrase | <enzyme> Enzyme of the human immunodeficiency virus that is required to integrate viral DNA into cellular DNA in the nucleus of a host cell. HIV integrase is a DNA nucleotidyltransferase encoded by the pol gene. Registry number: EC 2.7.7.- (12 Dec 1998) |
| HIV integrase inhibitors | Inhibitors of HIV integrase, an enzyme required for integration of viral DNA into cellular DNA. (12 Dec 1998) |
| HIV long-terminal repeat | Regulatory sequences important for viral replication that are located on each end of the HIV genome. The ltr includes the HIV enhancer, promoter, and other sequences. Specific regions in the ltr include the negative regulatory element (nre), nf-kappa b binding sites , sp1 binding sites, tata box, and trans-acting responsive element (tar). The binding of both cellular and viral proteins to these regions regulates HIV transcription. (12 Dec 1998) |
| HIV protease | <enzyme> Enzyme of the human immunodeficiency virus that is required for post-translational cleavage of gag and gag-pol precursor polyproteins into functional products needed for viral assembly. HIV protease is an aspartic protease encoded by the amino terminus of the pol gene. Registry number: EC 3.4.23.- (12 Dec 1998) |
| anti-HIV agents | Agents used to treat aids and/or stop the spread of the HIV infection. These do not include drugs used to treat symptoms or opportunistic infections associated with aids. (12 Dec 1998) |
|---|---|
| receptors, HIV | Cellular receptors that bind the human immunodeficiency virus that causes aids. Included are CD4 antigens, found on t4 lymphocytes, and monocytes/macrophages, which bind to the HIV envelope protein gp120. (12 Dec 1998) |
| chronic symptomatic HIV infection | This refers to an HIV infection that is characterised by signs and symptoms of HIV that are not life-threatening. Examples include oral thrush, gingivitis, seborrheic dermatitis, molluscum contangiosum, fevers, fatigue, lymph node swelling, malaise and weight loss. This stage can be a signal for the conversion from asymptomatic HIV disease to HIV disease (moe pronouced symptoms include joint pains). AIDS is diagnosed after HIV disease has started to manifest life-threatening oppotunistic infections (for example pneumocystis, cryptosporidium, toxoplasmosis, etc). (27 Sep 1997) |
| middle stage HIV disease | <disease> This refers to an HIV infection that is characterised by signs and symptoms of HIV that are not life-threatening. Examples include oral thrush, gingivitis, seborrheic dermatitis, molluscum contangiosum, fevers, fatigue, lymph node swelling, malaise and weight loss. This stage can be a signal for the conversion from asymptomatic HIV disease to HIV disease (moe pronouced symptoms include joint pains). AIDS is diagnosed after HIV disease has started to manifest life-threatening oppotunistic infections (for example pneumocystis, cryptosporidium, toxoplasmosis, etc). (27 Sep 1997) |
| primary HIV infection | <infectious disease> The flu-like syndrome that oc immediately after a person contracts HIV. This mini infection precedes seroconversion and is characterised fever, sore throat, headache, skin rash and swollen glands. (06 Mar 1998) |
Synonyms : Acquired Immune Deficiency Syndrome Virus, Acquired Immunodeficiency Syndrome Virus, Human Immunodeficiency Virus, Human T Cell Lymphotropic Virus Type III, Human T Lymphotropic Virus Type III, Human T-Cell Leukemia Virus Type III, AIDS Viruses, Virus, AIDS
Synonyms : HIV Associated Antibodies, HTLV III Antibodies, HTLV III LAV Antibodies, Lymphadenopathy Associated Antibodies, T Lymphotropic Virus Type III Antibodies, Human, Antibodies, AIDS, Antibodies, HIV, Antibodies, HIV Associated, Antibodies, HIV-Associated
Synonyms : HIV Associated Antigens, HTLV III Antigens, HTLV III LAV Antigens, Lymphadenopathy Associated Antigens, T Lymphotropic Virus Type III Antigens, Human, Antigens, AIDS, Antigens, HIV, Antigens, HIV Associated, Antigens, HIV-Associated, Antigens, HTLV III
Synonyms : HIV Protein p24, HTLV-III p24, HTLV III p24, p24 Antigen, HIV, p24, HIV Protein, p24, HTLV-III
Synonyms : HIV-1 Enhancer, NF-kB Binding Site, HIV, NF-kB-Binding Site, HIV, Enhancer, HIV, Enhancer, HIV-1, Enhancers, HIV, Enhancers, HIV-1, HIV 1 Enhancer, HIV Enhancers, HIV NF kappa B Binding Site, HIV NF-kB-Binding Site, HIV NF-kB-Binding Sites, HIV-1 Enhancers
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|---|---|---|---|
|
히비드정0.75mg - 새창
|
F.Hoffmann-La Roche |
E01840191 | Zalcitabine | 전문의약품 | 급여 | 분업예외의약품 |
|
하이비날에스정 - 새창
|
한독약품 |
Ascorbic Acid 96% granule, Calcium pantothenate, Cyanocobalamin 1% granule, Ferric fumarate, Folic Acid, Nicotinamide, Pyridoxine HCl, Riboflavin, Thiamine nitrate, Tocopherol acetate 50% Type SD | 일반의약품 | 비급여 |
| HIV |
infection by the human immunodeficiency virus human immunodeficiency virus: the virus that causes acquired immune deficiency syndrome (AIDS); it replicates in and kills the helper T cells
출처: wordnet.princeton.edu/perl/webwn
|
|---|---|
| hive |
store, like bees; "bees hive honey and pollen"; "He hived lots of information" a teeming multitude beehive: a man-made receptacle that houses a swarm of bees move together in a hive or as if in a hive; "The bee swarms are hiving" beehive: a structure that provides a natural habitation for bees; as in a hollow tree gather into a hive; "The beekeeper hived the swarm"
출처: wordnet.princeton.edu/perl/webwn
|
| hives |
urtication: an itchy skin eruption characterized by weals with pale interiors and well-defined red margins; usually the result of an allergic response to insect bites or food or drugs
출처: wordnet.princeton.edu/perl/webwn
|
| HIV encephalopathy |
HIV-related encephalopathy, a progressive primary encephalopathy caused by human immunodeficiency virus type I infection; it involves principally the subcortical white matter and deep gray nuclei and is manifested by a variety of cognitive, motor, and behavioral abnormalities. Called also AIDS dementia complex, AIDS e., and HIV encephalitis.
출처: www.mercksource.com/pp/us/cns/cns_hl_dorlands.jspz...
|
| HIV positive |
Infected with the human immunodeficiency virus (HIV), the cause of acquired immunodeficiency syndrome (AIDS).
출처: www.stjude.org/glossary
|
| hiv | the virus that causes acquired immune deficiency syndrome (AIDS) |
|---|---|
| hiv | a man-made receptacle that houses a swarm of bees |
| hiv | a teeming multitude |
| hiv | a structure that provides a natural habitation for bees |
| hiv | gather into a hive |
| hiv | move together in a hive or as if in a hive |
| hiv | store, like bees |
| hiv | keep or lay aside for future use |
| hiv | withdraw (money) and move into a different location, often secretly and with dishonest intentions |
| hiv | remove from a group and make separate |
| hiv | save up as for future use |
| hiv | an itchy skin eruption characterized by weals with pale interiors and well-defined red margins |
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|
